Cardiff Oncology (CRDF)
(Delayed Data from NSDQ)
$2.62 USD
+0.04 (1.55%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $2.61 -0.01 (-0.38%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.27 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | -4.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.01 |
Next Year | -1.05 |
EPS (TTM) | -0.91 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.13M | 0.14M | 0.55M | 0.61M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 0.20M | 0.22M | 0.78M | 1.01M |
Low Estimate | 0.05M | 0.05M | 0.40M | 0.20M |
Year ago Sales | 0.14M | 0.16M | 0.49M | 0.55M |
Year over Year Growth Est. | -10.71% | -15.63% | 12.70% | 10.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.27 | -0.27 | -1.01 | -1.05 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.27 | -0.28 | -1.04 | -1.04 |
High Estimate | -0.26 | -0.26 | -0.91 | -0.80 |
Low Estimate | -0.29 | -0.28 | -1.06 | -1.19 |
Year ago EPS | -0.22 | -0.21 | -0.93 | -1.01 |
Year over Year Growth Est. | -22.73% | -28.57% | -8.60% | -4.46% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 3 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.27 | -0.27 | -1.01 | -1.05 |
7 Days Ago | -0.27 | -0.27 | -1.01 | -1.05 |
30 Days Ago | -0.27 | -0.27 | -1.01 | -1.05 |
60 Days Ago | -0.27 | -0.27 | -0.98 | -1.06 |
90 Days Ago | -0.27 | -0.27 | -0.98 | -1.06 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.27 | -1.01 | -1.05 |
Zacks Consensus Estimate | -0.27 | -0.27 | -1.01 | -1.05 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.22 | -0.21 | -0.22 | NA |
Estimate | -0.25 | -0.25 | -0.26 | -0.29 | NA |
Difference | -0.01 | 0.03 | 0.05 | 0.07 | 0.04 |
Surprise | -4.00% | 12.00% | 19.23% | 24.14% | 12.84% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more